Rhenman & Partners Asset Management’s Pediatrix Medical MD Stock Holding History

Rhenman & Partners Asset Management’s Portfolio MD Stock Details MD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-124,674	Closed	-$4.11M	–	97
2018 Q4	$4.11M	Hold	124,674	–	–	0.47%	60
2018 Q3	$5.82M	Buy	+124,674	New	+$5.72M	0.58%	59
2017 Q1	–	Sell	-9,000	Closed	-$600K	–	108
2016 Q4	$600K	Hold	9,000	–	–	0.12%	86
2016 Q3	$596K	Sell	9,000 -71,000	-89%	-$4.86M	0.09%	92
2016 Q2	$5.79M	Buy	+80,000	New	+$5.5M	1.03%	36
2014 Q4	–	Sell	-44,000	Closed	-$2.41M	–	91
2014 Q3	$2.41M	Buy	44,000 +14,000	+47%	+$794K	0.71%	52
2014 Q2	$1.75M	Buy	+30,000	New	+$1.77M	0.52%	70

Other funds holding MD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Rhenman & Partners Asset Management's MD Position: Q1 2019 in Review

Rhenman & Partners Asset Management sold out of Pediatrix Medical (MD) in Q1 2019, closing a stake of 124,674 shares — an estimated $4.11M sold.

Rhenman & Partners Asset Management first reported a position in MD in Q2 2014 and held it in 7 quarters. The position peaked at $5.82M in Q3 2018. 297 funds tracked by Wall St. Rank hold MD as of Q1 2019.

Rhenman & Partners Asset Management reported no remaining Pediatrix Medical position as of Q1 2019 after selling out during the quarter.
Rhenman & Partners Asset Management sold 124,674 Pediatrix Medical shares in Q1 2019, an estimated $4.11M.
Rhenman & Partners Asset Management first reported a position in Pediatrix Medical in Q2 2014 and held it in 7 quarters.
Rhenman & Partners Asset Management's Pediatrix Medical position peaked at $5.82M in Q3 2018.
297 funds tracked by Wall St. Rank held Pediatrix Medical as of Q1 2019.

Based on Rhenman & Partners Asset Management's 13F filing for Q1 2019, filed 11 Apr 2019.